Epidemiology of hospitalisations caused by rubella in the general population in Spain (1997-2006);Epidemiología de las hospitalizaciones causadas por rubéola en la población general en España (1997-2006)

Anales del Sistema Sanitario de Navarra

Volumn 33, Issue 1, 2010, Pages 65-70

  Santos Sancho, Juana Ma ^a   Gil Prieto, R ^a   Alvaro Meca A ^a   Gil de Miguel, A ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Hospitalisation; Rubella; Spain; Vaccines

Indexed keywords

ARTICLE; ENCEPHALOMYELITIS; FEMALE; HEALTH CARE COST; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREGNANCY; RUBELLA; SPAIN; ADOLESCENT; ADULT; CHILD; COST; ECONOMICS; INFANT; MALE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COSTS AND COST ANALYSIS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; RUBELLA; SPAIN; YOUNG ADULT;

EID: 77952783959     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. ROBERTSON SE, FEATHERSTONE DA, GACIC-DOBO M, HERSH BS. Rubella and congenital rubella syndrome: global update. Rev Panam Salud Publica 2003; 14: 306-315. (Pubitemid 38056800)
2. Eliminating measles and rubella and preventing congenital rubella infection. 10 WHO european region strategic plan 2005-2010 WHO regional office for Europe 2005.
3. REEF SE, REDD SB, ABERNATHY E, ZIMMERMAN L, ICENOGLE JP. The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998-2004: the evidence for absence of endemic transmission. Clin Infect Dis 2006; 43 (Suppl. 3): S126-S132.
4. PELTOLA H, HEINONEN OP, VALL E M, PAUNIO M, VIRTANEN M, KARANKO V et al. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 1994; 331: 1397-1402.
5. PLOTKIN SA. Rubella eradication. Vaccine 2001; 19: 3311-3319.
6. Servicio de Vigilancia Epidemiológica, Centro Nacional de Epidemiología. Plan Nacional de Eliminación del Sarampión. España 2006. Ministerio de Sanidad y Consumo 2007.
7. World Health Organization. Surveillance guidelines for measles and congenital rubella infection in the who european region. http://www.euro.who. int/document/E82183.pdf (2003).
8. AMELA C, PACHON I, DE ORY F. Evaluation of the measles, mumps and rubella immunisation programme in Spain by using a sero-epidemiological survey. Eur J Epidemiol 2003; 18: 71-79.
9. MARTÍNEZ-TORRES AO, MOSQUERA MM, SANZ JC, RAMOS B, ECHEVARRÍA JE. Phylogenetic analysis of rubella virus strains from an outbreak in Madrid, Spain, from 2004 to 2005. J Clin Microbiol 2009; 47: 158-163.
10. HINMAN AR, IRONS B, LEWIS M, KANDOLA K. Economic analyses of rubella and rubella vaccines: a global review. Bull World Health Organ 2002; 80: 264-270.
11. RIVERO CUADRADO A. El conjunto mínimo básico de datos en el SNS: inicios y desarrollo actual. Rev Fuentes Estadísticas 2000; 49: 18-19.
12. SCHREYÖGG J, STARGARDT T, TIEMANN O, BUSSE R. Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries. Health Care Manag Sci 2006; 9: 215-223.
13. LÓPEZ-DE-ANDRÉS A, JIMÉNEZ-GARCÉA R, CARRASCO-GARRIDO P, VARO-MECA A, GALARZA PG, DE MIGUEL AG. Hospitalizations associated with rotavirus gastroenteritis in Spain, 2001-2005. BMC Public Health 2008; 8: 109.
14. Centers for Disease Control and Prevention. Rubella. En: Atkinson W, Hamborsky J, McIntyre L, Wolfe S, editors. Epidemiology and prevention of vaccine-preventable diseases. 10th ed. Washington DC: Public Health Foundation; 2008.